Literature DB >> 21325554

Fecal leukocytes in children infected with diarrheagenic Escherichia coli.

Erik H Mercado1, Theresa J Ochoa, Lucie Ecker, Martin Cabello, David Durand, Francesca Barletta, Margarita Molina, Ana I Gil, Luis Huicho, Claudio F Lanata, Thomas G Cleary.   

Abstract

The purpose of this study was to determine the presence and quantity of fecal leukocytes in children infected with diarrheagenic Escherichia coli and to compare these levels between diarrhea and control cases. We analyzed 1,474 stool samples from 935 diarrhea episodes and 539 from healthy controls of a cohort study of children younger than 2 years of age in Lima, Peru. Stools were analyzed for common enteric pathogens, and diarrheagenic E. coli isolates were studied by a multiplex real-time PCR. Stool smears were stained with methylene blue and read by a blinded observer to determine the number of polymorphonuclear leukocytes per high-power field (L/hpf). Fecal leukocytes at >10 L/hpf were present in 11.8% (110/935) of all diarrheal episodes versus 1.1% (6/539) in controls (P < 0.001). Among stool samples with diarrheagenic E. coli as the only pathogen isolated (excluding coinfection), fecal leukocytes at >10 L/hpf were present in 8.5% (18/212) of diarrhea versus 1.3% (2/157) of control samples (P < 0.01). Ninety-five percent of 99 diarrheagenic E. coli diarrhea samples were positive for fecal lactoferrin. Adjusting for the presence of blood in stools, age, sex, undernutrition, and breastfeeding, enterotoxigenic E. coli (ETEC) isolation as a single pathogen, excluding coinfections, was highly associated with the presence of fecal leukocytes (>10 L/hpf) with an odds ratio (OR) of 4.1 (95% confidence interval [CI], 1.08 to 15.51; P < 0.05). Although diarrheagenic E. coli was isolated with similar frequencies in diarrhea and control samples, clearly it was associated with a more inflammatory response during symptomatic infection; however, in general, these pathogens elicited a mild inflammatory response.

Entities:  

Mesh:

Year:  2011        PMID: 21325554      PMCID: PMC3122844          DOI: 10.1128/JCM.02199-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Fecal leukocytes in diarrheal illness.

Authors:  J C Harris; H L Dupont; R B Hornick
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

2.  Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

Authors:  David E Greenberg; Zhi-Dong Jiang; Robert Steffen; Mangala P Verenker; Herbert L DuPont
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

3.  Occult blood versus fecal leukocytes in the diagnosis of bacterial diarrhea: a study of U.S. travelers to Mexico and Mexican children.

Authors:  W S McNeely; H L Dupont; J J Mathewson; R A Oberhelman; C D Ericsson
Journal:  Am J Trop Med Hyg       Date:  1996-10       Impact factor: 2.345

4.  The prevalence and virulence characteristics of enteroaggregative Escherichia coli at an urgent-care clinic in the USA: a case-control study.

Authors:  David Cennimo; Atif Abbas; David B Huang; Tom Chiang
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

5.  Diagnostic accuracy of stool assays for inflammatory bacterial gastroenteritis in developed and resource-poor countries.

Authors:  Christopher J Gill; Joseph Lau; Sherwood L Gorbach; Davidson H Hamer
Journal:  Clin Infect Dis       Date:  2003-07-22       Impact factor: 9.079

6.  Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.

Authors:  David B Huang; Jamal A Mohamed; James P Nataro; Herbert L DuPont; Zhi-Dong Jiang; Pablo C Okhuysen
Journal:  J Med Microbiol       Date:  2007-10       Impact factor: 2.472

7.  Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru.

Authors:  Theresa J Ochoa; Lucie Ecker; Francesca Barletta; Mónica L Mispireta; Ana I Gil; Carmen Contreras; Margarita Molina; Isabel Amemiya; Hector Verastegui; Eric R Hall; Thomas G Cleary; Claudio F Lanata
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

8.  Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.

Authors:  Mohammed A Khan; Saeid Bouzari; Caixia Ma; Carrie M Rosenberger; Kirk S B Bergstrom; Deanna L Gibson; Theodore S Steiner; Bruce A Vallance
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

9.  Effect of Storage Time and Temperature on Fecal Leukocytes and Occult Blood in the Evaluation of Travelers' Diarrhea.

Authors: 
Journal:  J Travel Med       Date:  1994-12-01       Impact factor: 8.490

10.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.

Authors:  T Ruuska; T Vesikari
Journal:  Scand J Infect Dis       Date:  1990
View more
  14 in total

1.  Enterotoxigenic Escherichia coli prevents host NF-κB activation by targeting IκBα polyubiquitination.

Authors:  Xiaogang Wang; Philip R Hardwidge
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

2.  Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.

Authors:  Sarah N Buss; Amy Leber; Kimberle Chapin; Paul D Fey; Matthew J Bankowski; Matthew K Jones; Margarita Rogatcheva; Kristen J Kanack; Kevin M Bourzac
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

3.  Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Authors:  Lucie Etienne-Mesmin; Stéphanie Blanquet-Diot; Thomas Sauvaitre; Josefien Van Landuyt; Claude Durif; Charlène Roussel; Adeline Sivignon; Sandrine Chalancon; Ophélie Uriot; Florence Van Herreweghen; Tom Van de Wiele
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-20       Impact factor: 8.462

4.  Enteroaggregative coli: A Pathogen Bridging the North and South.

Authors:  Teresa Estrada-Garcia; Iza Perez-Martinez; Rodolfo Bernal-Reynaga; Mussaret B Zaidi
Journal:  Curr Trop Med Rep       Date:  2014-06-01

5.  Diarrheagenic Escherichia coli carrying supplementary virulence genes are an important cause of moderate to severe diarrhoeal disease in Mexico.

Authors:  Sandra Patzi-Vargas; Mussaret Bano Zaidi; Iza Perez-Martinez; Magda León-Cen; Alba Michel-Ayala; Damien Chaussabel; Teresa Estrada-Garcia
Journal:  PLoS Negl Trop Dis       Date:  2015-03-04

6.  Detection and drug resistance profile of Escherichia coli from subclinical mastitis cows and water supply in dairy farms in Saraburi Province, Thailand.

Authors:  Woranich Hinthong; Natapol Pumipuntu; Sirijan Santajit; Suphang Kulpeanprasit; Shutipen Buranasinsup; Nitat Sookrung; Wanpen Chaicumpa; Pisinee Aiumurai; Nitaya Indrawattana
Journal:  PeerJ       Date:  2017-06-13       Impact factor: 2.984

7.  Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut.

Authors:  Gaelle Noel; Michele Doucet; James P Nataro; James B Kaper; Nicholas C Zachos; Marcela F Pasetti
Journal:  Gut Microbes       Date:  2017-10-31

8.  Frequency of Listeria monocytogenes Isolated from Diarrhea Samples of Pediatric Patients at Central Iran.

Authors:  Elnaz Abbasi; Alireza Amouzandeh-Nobaveh; Ehsanollah Ghaznavi-Rad
Journal:  Rep Biochem Mol Biol       Date:  2019-07

9.  Role of enteropathogenic Escherichia coli in paediatric diarrhoeas in South India.

Authors:  Gandham Pavani Tilak; Jyothi Lakshmi G Mudaliar
Journal:  Mater Sociomed       Date:  2012

10.  Diagnostic value of the Vesikari Scoring System for predicting the viral or bacterial pathogens in pediatric gastroenteritis.

Authors:  Dong Ho Shim; Dong Yeon Kim; Ky Young Cho
Journal:  Korean J Pediatr       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.